Partilhar
Informação da revista
Número
Vol. 41. Núm. 11.Páginas 899-978 (novembro 2022)
Original articles
Optimal timing of intervention in non-ST-elevation acute coronary syndromes without pre-treatment
Inês Almeida, Joana Chin, Hélder Santos, Mariana Santos, Hugo Miranda, Samuel Almeida, Catarina Sousa, Lurdes Almeida
Rev Port Cardiol. 2022;41:899-907
Open access
Original Articles
Editorial comment
Pre-treatment with P2Y12 inhibitors: Old habits die hard
Catarina Brízido
Rev Port Cardiol. 2022;41:909-10
Open access
Relationship between oxytocin receptor gene polymorphism and hypertension in Turkish population
Merve M. Cicekliyurt, Begum Dermenci
Rev Port Cardiol. 2022;41:911-6
Open access
Original Articles
Editorial comment
Genetic determinants of arterial hypertension: A case of oxytocin receptor gene polymorphism
Steve Catarino
Rev Port Cardiol. 2022;41:917-8
Open access
Antiplatelet therapy at discharge and long-term prognosis in Takotsubo syndrome: Insights from the Spanish National Registry (RETAKO)
Eduardo Pereyra, Diego Fernández-Rodríguez, Silvia González-Sucarrats, Manuel Almendro-Delia, Agustín Martín, Irene Martin de Miguel, Mireia Andrés, Alberto Duran-Cambra, ... on behalf of the RETAKO investigators
Rev Port Cardiol. 2022;41:919-27
Open access
Original Articles
Editorial comment
Antithrombotics without intracoronary thrombus. The case of Takotsubo Syndrome
João Morais
Rev Port Cardiol. 2022;41:929-30
Open access
The effect of paclitaxel plus carboplatin chemotherapy on subclinical cardiotoxicity in patients with non-small cell lung cancer: A speckle tracking echocardiography-based study
Batur Gonenc Kanar, Akın Ozturk, Alper Kepez, Dursun Akaslan, Murat Kavas, Erhan Ogur, Kamil Gülşen, Akyan Küp, ... Beste Ozben
Rev Port Cardiol. 2022;41:931-8
Open access
Original Articles
Editorial comment
Cardiotoxicity: Will we ever unravel it?
Andreia Magalhães
Rev Port Cardiol. 2022;41:939-40
Open access
The MAGGIC risk score in the prediction of death or hospitalization in patients with heart failure: Comparison with natriuretic peptides
Felipe Mafort Rohen, Diane Xavier de Ávila, Carolina Martins Cabrita Lemos, Ricardo Santos, Mário Ribeiro, Humberto Villacorta
Rev Port Cardiol. 2022;41:941-7
Open access
Original Articles
Editorial comment
The trials and tribulations of risk prediction studies in heart failure
Daniel T. Mathew, Sanjiv J. Shah
Rev Port Cardiol. 2022;41:949-51
Open access
State of the art
Percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A review
Manuel Neto Martins
Rev Port Cardiol. 2022;41:953-68
Open access
State of the Art
Editorial comment
Left main disease: Have late trial results changed our knowledge and practice?
Nuno Carvalho Guerra
Rev Port Cardiol. 2022;41:969-70
Open access
Cardiac surgery is still necessary in the treatment of left main disease
José Roquette
Rev Port Cardiol. 2022;41:971-2
Open access
Case report
Iatrogenic ventricular fibrillation in Wolff-Parkinson-White syndrome
Alzira Nunes, Ana Lebreiro, Manuel Campelo, Luís Adão, Maria Júlia Maciel
Rev Port Cardiol. 2022;41:973.e1-973.e4
Open access
Original articles
Original Articles
Editorial comment
Pre-excited atrial fibrillation: A lower threshold for electrical cardioversion
Luís Elvas
Rev Port Cardiol. 2022;41:975-6
Open access
Image in cardiology
Tension pneumopericardium secondary to esophageal-pericardial fistula
Adriana Sarai Osuna Garibay, Cuitláhuac Arroyo-Rodríguez, José Roberto Victoria-Nandayapa, Jesús Francisco López-Borbón, Javier Alán Domínguez-Castillo, Luis-Enrique Parra-Menchaca
Rev Port Cardiol. 2022;41:977-8
Open access
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.